BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29208980)

  • 1. Long-term drug modification to the surface of mesenchymal stem cells by the avidin-biotin complex method.
    Takayama Y; Kusamori K; Hayashi M; Tanabe N; Matsuura S; Tsujimura M; Katsumi H; Sakane T; Nishikawa M; Yamamoto A
    Sci Rep; 2017 Dec; 7(1):16953. PubMed ID: 29208980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable Surface Modification of Mesenchymal Stem Cells Using the Avidin-Biotin Complex Technique.
    Kusamori K; Takayama Y; Nishikawa M
    Curr Protoc Stem Cell Biol; 2018 Nov; 47(1):e66. PubMed ID: 30303624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of avidin-like proteins and biotin modification on mesenchymal stem cell adhesion.
    Schmidt RC; Healy KE
    Biomaterials; 2013 May; 34(15):3758-62. PubMed ID: 23452388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy.
    Takayama Y; Kusamori K; Tsukimori C; Shimizu Y; Hayashi M; Kiyama I; Katsumi H; Sakane T; Yamamoto A; Nishikawa M
    J Control Release; 2021 Jan; 329():1090-1101. PubMed ID: 33098911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury.
    Shi W; Huang CJ; Xu XD; Jin GH; Huang RQ; Huang JF; Chen YN; Ju SQ; Wang Y; Shi YW; Qin JB; Zhang YQ; Liu QQ; Wang XB; Zhang XH; Chen J
    Acta Biomater; 2016 Nov; 45():247-261. PubMed ID: 27592818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward an ideal animal model to trace donor cell fates after stem cell therapy: production of stably labeled multipotent mesenchymal stem cells from bone marrow of transgenic pigs harboring enhanced green fluorescence protein gene.
    Hsiao FS; Lian WS; Lin SP; Lin CJ; Lin YS; Cheng EC; Liu CW; Cheng CC; Cheng PH; Ding ST; Lee KH; Kuo TF; Cheng CF; Cheng WT; Wu SC
    J Anim Sci; 2011 Nov; 89(11):3460-72. PubMed ID: 21705633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
    Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
    Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.
    Song H; Chang W; Lim S; Seo HS; Shim CY; Park S; Yoo KJ; Kim BS; Min BH; Lee H; Jang Y; Chung N; Hwang KC
    Stem Cells; 2007 Jun; 25(6):1431-8. PubMed ID: 17347495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells.
    Antebi B; Rodriguez LA; Walker KP; Asher AM; Kamucheka RM; Alvarado L; Mohammadipoor A; Cancio LC
    Stem Cell Res Ther; 2018 Oct; 9(1):265. PubMed ID: 30305185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall.
    Mirza A; Hyvelin JM; Rochefort GY; Lermusiaux P; Antier D; Awede B; Bonnet P; Domenech J; Eder V
    J Vasc Surg; 2008 Jun; 47(6):1313-21. PubMed ID: 18329228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma.
    Xiang J; Tang J; Song C; Yang Z; Hirst DG; Zheng QJ; Li G
    Cytotherapy; 2009; 11(5):516-26. PubMed ID: 19562576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α increases bone marrow mesenchymal stem cell migration to ischemic tissues.
    Xiao Q; Wang SK; Tian H; Xin L; Zou ZG; Hu YL; Chang CM; Wang XY; Yin QS; Zhang XH; Wang LY
    Cell Biochem Biophys; 2012 Apr; 62(3):409-14. PubMed ID: 22081437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
    Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
    Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends.
    Bhardwaj N; Kundu SC
    Biomaterials; 2012 Apr; 33(10):2848-57. PubMed ID: 22261099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Tracking and Regenerative Capabilities of Transplanted Human Umbilical Cord-Derived Mesenchymal Stem Cells Labeled with I-III-IV Semiconducting Nanocrystals in Liver-Injured Living Mice.
    Chetty SS; Praneetha S; Govarthanan K; Verma RS; Vadivel Murugan A
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8763-8778. PubMed ID: 30741534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Met-Activated Mesenchymal Stem Cells Rescue Ischemic Damage via Interaction with Cellular Prion Protein.
    Han YS; Yun SP; Lee JH; Kwon SH; Kim S; Hur J; Lee SH
    Cell Physiol Biochem; 2018; 46(5):1835-1848. PubMed ID: 29705776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward biomimetic materials in bone regeneration: functional behavior of mesenchymal stem cells on a broad spectrum of extracellular matrix components.
    Ode A; Duda GN; Glaeser JD; Matziolis G; Frauenschuh S; Perka C; Wilson CJ; Kasper G
    J Biomed Mater Res A; 2010 Dec; 95(4):1114-24. PubMed ID: 20878902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
    Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided evaluation and standardisation of mesenchymal stem cell culture conditions to generate conditioned medium favourable to cardiac c-kit cell growth.
    Ng WH; Umar Fuaad MZ; Azmi SM; Leong YY; Yong YK; Ng AMH; Tan JJ
    Cell Tissue Res; 2019 Feb; 375(2):383-396. PubMed ID: 30232595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.